Cameroon vs Morocco: Access to anti-retroviral drugs, female
Cameroon
95.0%
in 2024
Morocco
93.0%
in 2024
Cameroon rank
19th
Morocco rank
22nd
Access to anti-retroviral drugs, female over time
- Cameroon
- Morocco
How they compare
Cameroon currently reports 95.0% against 93.0% in Morocco, a difference of 2.0%.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Morocco ahead.
Cameroon ranks 19th and Morocco ranks 22nd of 141 countries.
Across the 3 decades both report, Cameroon averaged higher in 1 and Morocco in 2.
Head to head by decade
| Decade | Cameroon | Morocco | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4.2% | 6.0% | 1.8% | Morocco |
| 2010s | 38.0% | 38.3% | 0.3% | Morocco |
| 2020s | 86.6% | 82.2% | 4.4% | Cameroon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Cameroon or Morocco?
- Cameroon, at 95.0% against 93.0% in Morocco as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Cameroon and Morocco?
- 2.0%, with Cameroon ahead.
- How many years of comparable data are there for Cameroon and Morocco?
- 25 years are reported by both, from 2000 to 2024.
- How do Cameroon and Morocco rank globally for access to anti-retroviral drugs, female?
- Cameroon ranks 19th and Morocco ranks 22nd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.